Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7414 p210
19 August 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Pharmacy services need more effective promotion

Public perceptions of pharmacy need to be brought up to date to help patients make best use of the wide range of services pharmacies now offer. This was one of the key messages raised at the first evidence session of the All Party Pharmacy Group inquiry into the future of pharmacy, held in London last week.

Asthma UK and Which? both gave evidence at the session, which was hosted by the APPG’s chairman Howard Stoate (Lab, Dartford), Sandra Gidley (Lib Dem, Romsey) and Baroness Julia Cumberlege, former Conservative health minister and vice-president of the APPG.

Frances Blunden

Frances Blunden: consumer perceptions hinder pharmacy progress

Frances Blunden, principal policy adviser at Which?, said that consumer perceptions are one of the main barriers to the advancement of pharmacy, and that primary care trusts need to take a more active role in promoting the new services that pharmacy can offer. The reconfiguration of PCTs offers opportunities for them to enhance and develop their pharmacy expertise, she said.

Ms Blunden also highlighted Which? research indicating that pharmacies are not widely regarded as the natural first-stop for general health care and advice for most customers, and that customers have difficulty accessing pharmacies during the out-of-hours period.

She also said that if pharmacists are to take on a more clinical role they need to create an area in their pharmacy where patients feel comfortable having blood taken and sharing personal information, for example. Despite concerns about the lost income from taking up retail space with consultation areas, she pointed out that the Office of Fair Trading notes that it is the NHS contract that primarily makes community pharmacy profitable as a business.

Turning to the control-of-entry regulations, Ms Blunden said that Which? could not see any logic in defending them. Rather, Which? saw the regulations as “negative measures that do little to address the key questions of how to ensure high-quality, local pharmacy provision that gives good access to patient-centred service for everyone who needs them, when they need them.”

Simon Selo, assistant director, service development at Asthma UK, added that a survey of 200 asthma patients carried out by Asthma UK earlier this year showed that most asthma patients were unaware that their pharmacy could carry out medicines use reviews.

The next evidence session of the inquiry is due to be held after the Parliamentary summer recess.

Back to Top


©The Pharmaceutical Journal